Peer-influenced content. Sources you trust. No registration required. This is HCN.
Oncology News Central (ONC)
The FDA’s recent approval of toripalimab, based on the JUPITER-02 and POLARIS-02 clinical trials, marks a significant milestone in the treatment of nasopharyngeal carcinoma. With a median progression-free survival of 11.7 months, toripalimab has shown promising results in improving patient outcomes.
Medical Oncology November 6th 2023
Decisions in Dentistry
Gain actionable insights into managing oral health complications in radiation therapy patients; a valuable course for any dental professional committed to multidisciplinary care.
Dentistry September 18th 2023
Annals of Internal Medicine
Gain insights into the ethical and medical complexities of determining death with the ACP’s latest position paper. Equip yourself with the knowledge and guidelines to navigate this critical aspect of patient care.
All Specialties September 13th 2023
MDLinx
Learn more about the alarming trend of diagnostic delays in head and neck cancer patients due to inappropriate antibiotic prescribing, and why adhering to current clinical guidelines is more crucial than ever.
Medical Oncology September 11th 2023
The rise in oropharyngeal cancer rates, linked to high-risk HPV strains transmitted through oral sex, underscores the need for healthcare providers to promote safe sex practices, HPV vaccination, and early symptom recognition.
Medical Oncology August 7th 2023
British Dental Journal (BDJ)
Discover how the topical application of 1:1000 adrenaline could revolutionize your approach to managing bleeding in oral surgery and dentistry, potentially improving surgical outcomes and patient experiences.
Dentistry July 17th 2023